Biologics & Treatment
Vedolizumab Shows Superior Remission Rates in Long-Term Ulcerative Colitis Study
5-year GEMINI extension data confirms Entyvio maintains clinical and endoscopic remission in 60% of moderate-to-severe ulcerative colitis patients with a favorable long-term safety profile. No new safety signals identified.
Comparative Effectiveness of JAK Inhibitors vs. Biologics in Ulcerative Colitis
Systematic review of 28 trials comparing tofacitinib, upadacitinib, and filgotinib against anti-TNF and anti-integrin biologics. JAK inhibitors show faster onset with comparable 1-year remission rates.
Real-World Outcomes of Ustekinumab in Biologic-Experienced Ulcerative Colitis Patients
Multicenter cohort of 840 ulcerative colitis patients who failed prior anti-TNF therapy. Ustekinumab achieved clinical response in 68% at week 16, with steroid-free remission at 52 weeks in 44%.
Diet & Nutrition
Mediterranean Diet Linked to 40% Lower Ulcerative Colitis Flare Risk
Prospective cohort of 3,200 ulcerative colitis patients followed for 3 years. High adherence to Mediterranean dietary patterns was associated with significantly lower rates of hospitalization, steroid use, and endoscopic activity.
Dietary Fiber and Gut Microbiota in ulcerative colitis: A Mechanistic Overview
Review of 42 studies examining soluble vs. insoluble fiber intake in IBD. Soluble fiber (psyllium, oats) associated with improved mucosal healing; insoluble fiber may exacerbate symptoms during active disease.
Ultra-Processed Food Consumption and Ulcerative Colitis Disease Activity: Meta-Analysis
Meta-analysis of 19 observational studies (n = 22,000+). High ultra-processed food intake was associated with a 49% increased risk of ulcerative colitis relapse compared to whole-food dietary patterns.
Digital Health & AI
AI Analysis of Ulcerative Colitis Treatment Response Patterns Across Patient Cohorts
Deep learning model trained on colonoscopy images combined with patient-reported outcome measures enables precision medicine approaches for biologic selection, achieving 82% accuracy in predicting non-response.
Patient-Generated Health Data in IBD: Accuracy and Clinical Utility
Evaluation of smartphone-based symptom tracking in 380 ulcerative colitis patients over 12 months. Patient-reported bowel frequency correlated strongly with endoscopic Mayo sub-scores (r = 0.74, p < 0.001).
Sleep & Lifestyle
Sleep Disruption Increases Ulcerative Colitis Flare Risk Threefold
Ulcerative colitis patients sleeping fewer than 6 hours per night showed 3× higher disease activity scores at follow-up, independent of medication use and stress levels, establishing sleep hygiene as a modifiable risk factor.
Psychological Stress as a Trigger for Ulcerative Colitis Relapse: A Prospective Study
392 ulcerative colitis patients in remission followed for 18 months. High perceived stress scores predicted relapse within 6 weeks (HR 2.8, 95% CI 1.9,4.1). Stress-reduction interventions reduced relapse rates by 31%.
Note: Ulcerative Colitis Insights integrates findings from 20,000+ PubMed publications into its AI analysis layer. The publications listed here are a representative selection of key studies referenced during platform development. PubMed links open the National Library of Medicine database. Ulcerative Colitis Insights is not affiliated with any of the listed journals or authors.